Loading...
Cariprazine for acute and maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy
Cariprazine is an oral antipsychotic approved in the US and EU for the treatment of schizophrenia. Cariprazine differs from other antipsychotics in that it is a dopamine D(3)- and D(2)-receptor partial agonist, with tenfold higher affinity for D(3) receptors than for D(2) receptors. Cariprazine is m...
Na minha lista:
| Udgivet i: | Neuropsychiatr Dis Treat |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6179724/ https://ncbi.nlm.nih.gov/pubmed/30323605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S159704 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|